32 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
or is expected to cause material and demonstrable injury to us; or (iii) their conviction of, or a plea of nolo contendere to, a crime constituting (A) a felony
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
% -na- Congestion 3.1% / 4.9% 15% -19.7% -na- Package-related injury / laceration 0% / 0% 1.7% ?? % of subjects who withdrew from open- 4.1% (ASCEND … Laceration risk from metal band on vial; in Impel Ph3 safety trial, 2-3% of subjects reported ”Package-associated injury.” FDA AE reporting system contains
DEF 14A
71yh6hvft26
24 Apr 20
Definitive proxy
4:14pm
10-K
64bq0q6
10 Mar 20
Annual report
4:20pm
10-Q
nxmz9r
12 Nov 19
Quarterly report
4:31pm
424B4
dmls7rb7b9cy89q
13 Sep 19
Prospectus supplement with pricing info
5:08pm